Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2010
11/25/2010US20100298203 Sdf-i-based glycosaminoglycan antagonists and methods of using same
11/25/2010US20100298201 Peptidomimetic macrocycles with improved properties
11/25/2010US20100298152 Use of aptamers in proteomics
11/25/2010US20100297762 Photodynamic therapy using chemiluminescence and a ligand-photosensitiser conjugate
11/25/2010US20100297758 Artificial peptide and use thereof
11/25/2010US20100297734 Fusion Tag Comprising an Affinity Tag and an EF-Hand Motif Containing Polypeptide and Methods of Use Thereof
11/25/2010US20100297732 Vectors with modified protease-dependent tropism
11/25/2010US20100297730 Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
11/25/2010US20100297703 Lytic Enzyme Inhibitor, Lysis Inhibitor, Inhibitor of Poly-y-glutamic Acid Degradation, and Method for Producing Poly- y-glutamic Acid
11/25/2010US20100297702 Protein markers associated with bone marrow stem cell differentiation into early progenitor dendritic cells
11/25/2010US20100297697 Methods for increasing protein titers
11/25/2010US20100297695 Nucleic Acids Encoding Chimeric CD154 Polypeptides
11/25/2010US20100297694 Novel gene from hancenula polymorpha capable of controlling unfolded protein response and method for increasing effect of secretion using the same
11/25/2010US20100297693 Production of carrier-peptide conjugates using chemically reactive unnatural amino acids
11/25/2010US20100297679 Identification and quantification of biomarkers for evaluating the risk of preterm birth
11/25/2010US20100297669 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 191P4D12(b) USEFUL IN TREATMENT AND DETECTION OF CANCER
11/25/2010US20100297664 Paratope and epitope of anti-mortalin antibody
11/25/2010US20100297650 Nucleic acid and corresponding protein entitled 193p1e1b useful in treatment and detection of cancer
11/25/2010US20100297638 Molecular adaptors
11/25/2010US20100297636 Cc2d2a gene mutations associated with joubert syndrome and diagnostic methods for identifying the same
11/25/2010US20100297632 Upregulation of rack-1 in melanoma and its use as a marker
11/25/2010US20100297623 NOVEL HUMAN ssDNA BINDING PROTEINS AND METHODS OF CANCER DIAGNOSIS
11/25/2010US20100297613 Nucleic acid, amino acid encoded by said nucleic acid, probe comprising said nucleic acid or said amino acid, and screening method using said probe
11/25/2010US20100297606 IgG BINDING PEPTIDE
11/25/2010US20100297219 Methods and Compositions for Modifying Apolipoprotein B mRNA Editing
11/25/2010US20100297187 Peptide sequences and compositions
11/25/2010US20100297183 Immunogenic streptococcus proteins
11/25/2010US20100297178 Novel genes and proteins of brachyspira hyodysenteriae and use of same for diagnosis and therapy
11/25/2010US20100297177 Mutated parvovirus structural proteins as vaccines
11/25/2010US20100297174 Influenza virus vaccines and uses thereof
11/25/2010US20100297171 Development of a preventive vaccine for filovirus infection in primates
11/25/2010US20100297170 Vaccines
11/25/2010US20100297169 Novel Neutralizing Immunogen (NIMIV) of Rhinovirus and its Use for Vaccine Applications
11/25/2010US20100297163 Recombinant malaria vaccine
11/25/2010US20100297162 S. epidermidis antigens
11/25/2010US20100297158 Anticancer vaccine and diagnostic methods and reagents
11/25/2010US20100297149 Compositions and methods comprising histidyl-trna synthetase splice variants having non-canonical biological activities
11/25/2010US20100297148 Cd38 modulated chemotaxis
11/25/2010US20100297144 Multitype hpv peptide compositions and methods for treatment or prevention of human papillomavirus infection
11/25/2010US20100297136 Gastric and Prostate Cancer Associated Antigens
11/25/2010US20100297135 Epitope for neutralizing antibodies
11/25/2010US20100297131 Binding domain of plasmodium reticulocyte binding proteins
11/25/2010US20100297124 Induced internalization of surface receptors
11/25/2010US20100297109 Methods for inhibiting fascin
11/25/2010US20100297108 Method of providing patient specific immune response in amyloidoses and protein aggregation disorders
11/25/2010US20100297093 Modified t cell receptors and related materials and methods
11/25/2010US20100297083 Polynucleotides and Polypeptide of Human KV1.3, Compositions Comprising Same and Methods of Using Same
11/25/2010US20100297080 Genetic markers associated with interferon-alpha response
11/25/2010US20100297078 Method for producing a hydroxyalkyl starch derivative with two linkers
11/25/2010US20100297076 Targeted interferon demonstrates potent apoptotic and anti-tumor activities
11/25/2010US20100297071 Immune response inducer
11/25/2010US20100297070 COMPOSITIONS AND METHODS FOR AMELIORATING CNS INFLAMMATION, PSYCHOSIS, DELIRIUM, PTSD or PTSS
11/25/2010US20100297069 Pegylated interleukin-10
11/25/2010US20100297068 Methods for treating viral infection using il-28 and il-29
11/25/2010US20100297065 Homogeneous preparations of il-31
11/25/2010US20100297064 Cytokine zalpha11 ligand antibodies
11/25/2010US20100297063 Cytokine zalpha11 ligand antibodies
11/25/2010US20100297021 Variants of C-Type Natriuretic Peptide
11/25/2010US20100297011 Isolated peptides and uses thereof
11/25/2010US20100297006 NUCLEIC ACIDS AND CORRESPONDING PROTEINS ENTITLED 191P4D12(b) USEFUL IN TREATMENT AND DETECTION OF CANCER
11/25/2010US20100297005 Nucleic acids and corresponding protein entitled 125p5c8 useful in treatment and detection of cancer
11/25/2010US20100297003 Anti-human tenascin monoclonal antibody
11/25/2010US20100294716 Templated Native Silk Smectic Gels
11/25/2010DE112008002848T5 Pflanzen mit verbesserten Ertragsmerkmalen und Verfahren zu ihrer Herstellung Plants having enhanced yield characteristics and methods for their preparation
11/25/2010DE102009022772A1 Mikroorganismus zur Expression eines humanen Membranproteins Microorganism for expression of a human membrane protein
11/25/2010CA2764931A1 Engineered type iv pilin of clostridium difficile
11/25/2010CA2762679A1 Compositions and methods to prevent cancer by stabilizing p53 through non mdm2-mediated pathways
11/25/2010CA2762604A1 Bifunctional polypeptides
11/25/2010CA2758581A1 Variants of c-type natriuretic peptide
11/25/2010CA2755948A1 Inhibition of prion protein propagation by receptor associated protein (rap), its derivatives, mimetics and synthetic peptides
11/24/2010EP2253709A1 Recombinant poxvirus expressing homologous genes inserted into the poxviral genome
11/24/2010EP2253708A1 Suppresion of specific classes of soybean seed protein genes
11/24/2010EP2253707A2 Expec-specific proteins, genes encoding them and uses thereof
11/24/2010EP2253703A1 Human coagulation factor VII variants
11/24/2010EP2253645A2 Factor VIII Polypeptide
11/24/2010EP2253644A1 Compositions and methods for producing a composition
11/24/2010EP2253643A1 Novel compositions and methods in cancer associated with altered expression of PRLR
11/24/2010EP2253642A1 Polypeptides, cDNAs encoding the same and utilization thereof
11/24/2010EP2253326A1 Pharmaceutical composition for transnasal administration
11/24/2010EP2253324A1 Use of a casein-derived peptide and compositions thereof as antihypertensive
11/24/2010EP2252729A1 Biomarkers for head-and-neck cancers and precancers
11/24/2010EP2252634A1 Hybrid polypeptides comprising gbs-80 and spb1 proteins of streptococcus
11/24/2010EP2252632A1 Antibodies directed to angiopoietin-1 and angiopoietin-2 and use thereof
11/24/2010EP2252630A2 Chimeric c3-like rho antagonist bone therapeutic
11/24/2010EP2252629A2 Use of defensins against tuberculosis
11/24/2010EP2252627A1 Lytic domain fusion constructs and methods of making and using same
11/24/2010EP2252329A2 Elimination of immune responses to viral vectors
11/24/2010EP1929303B1 Assay and kits therefor
11/24/2010EP1913400B1 Il-32 modulators
11/24/2010EP1780270B1 A detoxifizyme having activity of transforming aflatoxin and the gene encodes thereof
11/24/2010EP1651756B1 Scaffold-free self-organized 3d synthetic tissue
11/24/2010EP1651263B1 Safe mutant viral vaccines
11/24/2010EP1546375B1 Nucleic acids, polypeptides, and methods for modulating apoptosis
11/24/2010EP1539798B1 Process for protein extraction
11/24/2010EP1527088B1 Pegylated t20 polypeptide
11/24/2010EP1502949B1 Antimicrobial polypeptide and utilization thereof
11/24/2010EP1443954B1 Targeted thrombosis by tissue factor polypeptides
11/24/2010EP1355919B1 Molecules with extended half-lives, compositions and uses thereof
11/24/2010EP0804572B1 Fusion protein comprising bpTK7
11/24/2010EP0444181B2 C-erbb-2 external domain: gp75
1 ... 447 448 449 450 451 452 453 454 455 456 457 458 459 460 461 462 463 464 465 466 467 ... 2916